Cargando…

NMI: a potential biomarker for tumor prognosis and immunotherapy

N-Myc and STAT Interactor protein (NMI) is an interferon inducible protein participating in various cellular activities, and is widely involved in the process of tumorigenesis and progression. Studies have shown that the loss of NMI expression in breast cancer can promote its progression by inducing...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Teng, Qiao, Yinbiao, Yang, Qi, Chen, Jie, Chen, Yongyuan, Chen, Xiaoke, Hao, Zhixing, Lin, Mingjie, Shao, Zheyu, Wu, Pin, Xu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727384/ https://www.ncbi.nlm.nih.gov/pubmed/36506566 http://dx.doi.org/10.3389/fphar.2022.1047463

Ejemplares similares

NMI and EMT
por: Samant, Rajeev S., et al.
Publicado: (2014)

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
por: Wang, Jingshu, et al.
Publicado: (2017)

The immune landscape of human thymic epithelial tumors
por: Xin, Zhongwei, et al.
Publicado: (2022)

Tissue‐resident CD69(+)CXCR6(+) Natural Killer cells with exhausted phenotype accumulate in human non‐small cell lung cancer
por: Chen, Xiaoke, et al.
Publicado: (2022)

Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation
por: He, Teng, et al.
Publicado: (2022)

CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer
por: Wu, Pin, et al.
Publicado: (2021)

When Measurements Meet Blockchain: On Behalf of an Inter-NMI Network †
por: Moni, Mahbuba, et al.
Publicado: (2021)

NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
por: Feng, Xu, et al.
Publicado: (2017)

Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors
por: Alsheikh, Heba Allah M., et al.
Publicado: (2021)

NMI mediates transcription-independent ARF regulation in response to cellular stresses
por: Li, Zengpeng, et al.
Publicado: (2012)

Facile Amide Bond Formation with TCFH–NMI in an Organic Laboratory Course
por: M. Baldwin, Oliver W., et al.
Publicado: (2022)

Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma
por: Qi, Lin, et al.
Publicado: (2023)

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
por: Chen, Shuzhao, et al.
Publicado: (2023)

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer
por: Ma, Yiming, et al.
Publicado: (2022)

NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury
por: Xiahou, Zhikai, et al.
Publicado: (2017)

URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)

Network programmability with YANG: the structure of network automation with YANG, NETCONF, RESTCONF, and gNMI
por: Claise, Benoit, et al.
Publicado: (2019)

NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway
por: Zhao, Jing, et al.
Publicado: (2017)

Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning
por: Qi, Lin, et al.
Publicado: (2023)

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer
por: Hao, Zhixing, et al.
Publicado: (2022)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
por: Lv, Wenchang, et al.
Publicado: (2022)

Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
por: Liu, Yilong, et al.
Publicado: (2022)

Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma
por: Xia, Qin-Xuan, et al.
Publicado: (2022)

Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments
por: Qi, Lin, et al.
Publicado: (2023)

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
por: Liu, Jinhua, et al.
Publicado: (2021)

Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy
por: Li, Yunyue, et al.
Publicado: (2023)

Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
por: Li, Shuo, et al.
Publicado: (2023)

Ginsenosides: Allies of gastrointestinal tumor immunotherapy
por: Feng, Yutao, et al.
Publicado: (2022)

Serine and glycine metabolism-related gene expression signature stratifies immune profiles of brain gliomas, and predicts prognosis and responses to immunotherapy
por: Chen, Siliang, et al.
Publicado: (2022)

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer
por: Su, Duntao, et al.
Publicado: (2023)

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
por: Yan, Zhonghong, et al.
Publicado: (2021)

Comprehensive Analysis of Necroptosis in Pancreatic Cancer for Appealing its Implications in Prognosis, Immunotherapy, and Chemotherapy Responses
por: Fang, Kun, et al.
Publicado: (2022)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
por: Jiang, Aimin, et al.
Publicado: (2023)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

CLP1 is a Prognosis-Related Biomarker and Correlates With Immune Infiltrates in Rheumatoid Arthritis
por: Zhao, Zhenyu, et al.
Publicado: (2022)

A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma
por: Feng, Wentao, et al.
Publicado: (2023)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer
por: Yu, Yunhe, et al.
Publicado: (2022)

Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer
por: Deng, Langmei, et al.
Publicado: (2022)

The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
por: Zhong, Qing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o07f4nh8svs3gvqa4n2at2clgi